» Articles » PMID: 22470856

Interactions Between Thyroid Disorders and Kidney Disease

Overview
Specialty Endocrinology
Date 2012 Apr 4
PMID 22470856
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

There are several interactions between thyroid and kidney functions in each other organ's disease states. Thyroid hormones affect renal development and physiology. Thyroid hormones have pre-renal and intrinsic renal effects by which they increase the renal blood flow and the glomerular filtration rate (GFR). Hypothyroidism is associated with reduced GFR and hyperthyroidism results in increased GFR as well as increased renin - angiotensin - aldosterone activation. Chronic kidney disease (CKD) is characterized by a low T3 syndrome which is now considered a part of an atypical nonthyroidal illness. CKD patients also have increased incidence of primary hypothyroidism and subclinical hypothyroidism. The physiological benefits of a hypothyroid state in CKD, and the risk of CKD progression with hyperthyroidism emphasize on a conservative approach in the treatment of thyroid hormone abnormalities in CKD. Thyroid dysfunction is also associated with glomerulonephritis often by a common autoimmune etiology. Several drugs could affect both thyroid and kidney functions. There are few described interactions between thyroid and renal malignancies. A detailed knowledge of all these interactions is important for both the nephrologists and endocrinologists for optimal management of the patient.

Citing Articles

Thyroid hormone replacement therapy in dialysis/renal insufficiency patients.

Zhao X, Liu F, Yuan S, Wang F, Li C, Guo C Front Endocrinol (Lausanne). 2025; 16:1540802.

PMID: 40078580 PMC: 11897748. DOI: 10.3389/fendo.2025.1540802.


A Comparative Study of Euthyroid and Primary Hypothyroid Patients in End Stage Renal Disease (ESRD) Undergoing Maintenance Hemodialysis (MHD) in a Tertiary Care Hospital in Salem, Tamil Nadu.

Vijayasamundeeswari C, Jayachandrababu B, Kundu S, Parhi K, Ronald P, Periasamy P J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4555-S4558.

PMID: 40061716 PMC: 11888765. DOI: 10.4103/jpbs.jpbs_1221_24.


Recent advances in nanomedicine for the diagnosis and therapy of thyroid disorders.

Sahare P, Ruiz-Manriquez L, Anguiano B, Banerjee A, Pathak S, Duttaroy A 3 Biotech. 2025; 15(3):67.

PMID: 40012722 PMC: 11850684. DOI: 10.1007/s13205-025-04234-4.


Assessment of Renal Function in Patients with Chronic Kidney Disease with and without Hypothyroidism.

Mallina P, Rajan V, Kumar E, Prasad G Ethiop J Health Sci. 2025; 35(1):20-27.

PMID: 39981326 PMC: 11837789. DOI: 10.4314/ejhs.v35i1.4.


Thyroid Dysfunction in Patients With End-Stage Renal Disease: A Single-Centered Experience From Pakistan.

German S, Bhatti S, Waqar T, Lashari S, Mehmood M, Rizwan A Cureus. 2025; 17(1):e76715.

PMID: 39897291 PMC: 11783201. DOI: 10.7759/cureus.76715.


References
1.
Bradley S, COELHO J, SEALEY J, Edwards K, Stephan F . Changes in glomerulotubular dimensions, single nephron glomerular filtration rates and the renin-angiotensin system in hypothyroid rats. Life Sci. 1982; 30(7-8):633-9. DOI: 10.1016/0024-3205(82)90279-x. View

2.
Lin H, Tang M . Thyroid hormone upregulates Na,K-ATPase alpha and beta mRNA in primary cultures of proximal tubule cells. Life Sci. 1997; 60(6):375-82. DOI: 10.1016/s0024-3205(96)00661-3. View

3.
Ozen K, Asci G, Gungor O, Carrero J, Kircelli F, Tatar E . Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol. 2011; 33(4):305-12. DOI: 10.1159/000324883. View

4.
Crowley Jr W, Ridgway E, Bough E, Francis G, Daniels G, Kourides I . Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med. 1977; 296(1):1-6. DOI: 10.1056/NEJM197701062960101. View

5.
Katz A, Emmanouel D, Lindheimer M . Thyroid hormone and the kidney. Nephron. 1975; 15(3-5):223-49. DOI: 10.1159/000180514. View